i'm looking at the positives from that article - let's hope this...

i'm looking at the positives from that article - let's hope this is us...

"The lucky ones find buyers among bigger pharmaceutical companies to keep research programs alive. That’s what happened to Redwood City, California-based Genelabs Technologies Inc., a developer of hepatitis C treatments, which agreed on Oct. 29 to be bought by GlaxoSmithKline Plc, Europe’s biggest drugmaker, for $57 million. Genelabs’ market value had plunged to $10 million and its stock had lost 82 percent of its value this year before the deal was announced."

a takeover now is really our only hope. and the longer time goes by, the less confident i get. still, i'm in this one til the end now. good luck to us.

-j